Highly immunogenic inactivated cell culture vaccines for immunization of dogs via the parenteral route are now widely available on the international market at a cost affordable to more and more dog owners in the developing world. In addition, the trend towards transfer or acquisition of modern cell culture technology for parenteral veterinary vaccine production is increasing in developing countries particularly in Asia.